ArticlePloS one2011

Targeting MAGE-C1/CT7 expression increases cell sensitivity to the proteasome inhibitor bortezomib in multiple myeloma cell lines.

Fabricio de Carvalho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.